Sodium acid, sodium phosphate (Adco Fosenema)
Sodium acid, sodium phosphate
Adcock Ingram Critical Care (Pty) Ltd
Registration
- Applicant
- Adcock Ingram Critical Care (Pty) Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Adco fosenema EACH 150 ml CONTAINS SODIUM ACID PHOSPHATE 24 g SODIUM PHOSPHATE 9 g | Not listed | F0054F/11.5/54 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S3: Sodium phosphate
- in preparations intended for the management of faecal impaction or for bowel cleansing prior to surgical and diagnostic procedures. (S0)
Consolidated Schedules 06 July 2026, lines 4251 to 4252
1 of 1 approved products with this ingredient carry S4 on their leaflet.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.